Mitral Butterfly

Ticar, Johanna; Gaidulis, Gediminas; Veith, Kenzie; Rath, Claus; Jarman, Jeremy; Möhl, Werner

doi:10.1016/j.jacbts.2020.08.007

Search citation statements

Order By: Relevance

Paper Sections

Select...

Favorable Safety Profile1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2021

2024

Publication Types

Select...

Article4

Book1

Relationship

Self Cite0

Independent5

Authors

Journals

Cited by 5 publications

(1 citation statement)

References 16 publications

(21 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…An ideal TMVr device does not require anticoagulation. A promising concept of transcatheter papillary muscular repair commenced, named Mitral Butterfly (AVVie, Vienna, Austria), but the thrombogenic potential of the device has not been studied clearly ( 14 ). Therefore, only CE marker–approved devices deemed with safety profiles are pooled in our further discussion ( Table 2 , Figure 1 ).…”

Section: Favorable Safety Profilementioning

confidence: 99%

What Is the Next Generation of Transcatheter Mitral Valve Repair Devices?

Chen

Sun

2021

Front. Cardiovasc. Med.

View full text Add to dashboard Cite

In the evolving scenario of the transcatheter mitral valve repair (TMVr), TMVr devices constitute a rapidly expanding field. The standard classification includes edge-to-edge repair, direct annuloplasty, indirect annuloplasty, chordal/papillary muscular repair, and the others. However, the unknowns and uncertainties to innovate a high-performing device are addressed. In this viewpoint, the authors discuss the potential future of the next generation and the challenges of TMVr devices.

show abstract

Section: Favorable Safety Profilementioning

confidence: 99%